CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹3,481 Cr | ₹3,134 Cr | ₹2,563 Cr | ₹1,507 Cr | ₹1,031 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
Year | Short Term Loans and Advances |
---|---|
Mar2025 | ₹3,481 Cr |
Mar2024 | ₹3,134 Cr |
Mar2023 | ₹2,563 Cr |
Mar2022 | ₹1,507 Cr |
Mar2021 | ₹1,031 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2025 | ₹3,481 Cr | 11.08 | |
Mar2024 | ₹3,134 Cr | 22.28 | |
Mar2023 | ₹2,563 Cr | 70.07 | |
Mar2022 | ₹1,507 Cr | 46.18 | |
Mar2021 | ₹1,031 Cr | - |
Compare Short Term Loans and Advances of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹127,131.6 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹106,486.0 Cr | 0.1% | 6.1% | 6.2% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.1% |
3.5% |
-4.4% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses